<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="18445" whole_study_id="5351" phs="000126" v="2" p="1" createDate="2016-02-09T12:23:31-05:00" completedByGPADate="2016-07-29T16:15:00-05:00" modDate="2019-07-19T13:31:28-05:00" maxParentChildStudyModDate="2019-07-19T13:31:28-05:00" handle="CIDR_PD" num_participants=""><StudyInfo accession="phs000126.v2.p1" parentAccession="phs000126.v2.p1"><BioProject id="PRJNA75373" entrez_id="75373" type="bp_admin_access"/><BioProject id="PRJNA75375" entrez_id="75375" type="bp_data_submission"/><StudyNameReportPage>http://www.jhu.edu/</StudyNameReportPage><StudyNameEntrez>CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) </StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType></StudyTypes><Publications><Publication><Unparsed>Nichols WC, Elsaesser VE, Pankratz N, Pauciulo MW, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Parkinson Study Group-PROGENI Investigators. 
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. 
Neurology. 2007 Oct 30; 69(18):1737-44. 
Note:PROGENI 

Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group-PROGENI Investigators. 
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. 
Mov Disord. 2006 Dec; 21(12):2257-60. 
Note:PROGENI 

Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group - PROGENI Investigators. 
Mutations in DJ-1 are rare in familial Parkinson disease. 
Neurosci Lett. 2006 Nov 20; 408(3):209-13. 
Note:PROGENI 

Nichols WC, Pankratz N, Hernandez D, Pais?Ru?C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T, Parkinson Study Group-PROGENI investigators. 
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. 
Lancet. 2005 Jan 29-Feb 4; 365(9457):410-2. 
Note:PROGENI 

Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Berg CJ, Sun M, Goldwurm S, Pezzoli G, Racette BA, Perlmutter JS, Parsian A, Baker KB, Giroux ML, Litvan I, Pramstaller PP, Nicholson G, Burn DJ, Chinnery PF, Vieregge P, Slevin JT, Cambi F, MacDonald ME, Gusella JF, Myers RH, Golbe LI. 
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. 
Neurology. 2006 Dec 26; 67(12):2206-10. 
Note:GenePD 

Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. 
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. 
Arch Neurol. 2006 Jun; 63(6):826-32. 
Note:GenePD 

Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, Prakash R, Tobin S, Williamson J, Suchowersky O, Labell N, Growdon BN, Singer C, Watts R, Goldwurm S, Pezzoli G, Baker KB, Giroux ML, Pramstaller PP, Burn DJ, Chinnery P, Sherman S, Vieregge P, Litvan I, Gusella JF, Myers RH, Parsian A. 
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. 
Neurology. 2005 Dec 13; 65(11):1823-5. 
Note:GenePD 

Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, DeStefano AL, Latourelle JC, Xu G, Watts R, Growdon J, Lew M, Waters C, Vieregge P, Pramstaller PP, Klein C, Racette BA, Perlmutter JS, Parsian A, Singer C, Montgomery E, Baker K, Gusella JF, Herbert A, Myers RH. 
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. 
Mov Disord. 2005 Sep; 20(9):1188-91. 
Note:GenePD 

</Unparsed></Publication></Publications><Funding>R01 NS037167-10</Funding></StudyInfo><Authority><ICs><IC id="7" name="NINDS" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="TFOROUD" aid="2" auth="eRA" login="TFOROUD" fname="TATIANA" mname="M." lname="FOROUD" email="tforoud@iu.edu"><Role>PI</Role><Organization>INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS</Organization></Person><Person nedid="0013238013" aid="1" auth="cit" login="sutherlandm" fname="Margaret" mname="L" lname="Sutherland" email="sutherlandm@ninds.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010146585" aid="1" auth="cit" login="zhangr" fname="Ran" mname="" lname="Zhang" email="zhangr@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>INSTRUCTIONS:  This study has not provided a suggested acknowledgement statement. However, Approved Users are expected to acknowledge the Submitting Investigator(s) who submitted data from the original study to an NIH-designated data repository, the primary funding organization that supported the Submitting Investigator(s), and the NIH-designated data repository (e.g., dbGaP).  The acknowledgment statement should include the dbGaP accession number to the specific version of the dataset(s) analyzed.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="3" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="53" dac_name="NINDS" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="4" CGType="cg_class_DS" title="Disease-Specific (Parkinson's Disease and Related Disorders, NPU)" name="DS-PDRD-NPU" dac_uid="53" dac_name="NINDS" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Parkinson's Disease and Related Disorders.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="3"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="5351" whole_study_id="5351" phs="000126" v="1" p="1" createDate="2008-09-23T11:15:00-05:00" completedByGPADate="2015-12-09T11:37:11-05:00" modDate="2020-09-01T11:19:52-05:00" maxParentChildStudyModDate="2020-09-01T11:19:52-05:00" handle="CIDR_PD" num_participants=""><StudyInfo accession="phs000126.v1.p1" parentAccession="phs000126.v1.p1"><BioProject id="PRJNA75373" entrez_id="75373" type="bp_admin_access"/><BioProject id="PRJNA75375" entrez_id="75375" type="bp_data_submission"/><StudyNameReportPage>http://www.jhu.edu/</StudyNameReportPage><StudyNameEntrez>CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) </StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType></StudyTypes><Description>
&lt;p&gt;This proposal brings together the two largest NIH funded genetic studies focused on the identification of novel genes that

    influence the risk of PD. These two studies, PROGENI (PI: Tatiana Foroud; R01NS037167) and GenePD (PI: Richard Myers; R01NS036711)

    have been evaluating and recruiting families with two or more PD affected members for more than 8 years and represent the

    largest such cohorts world-wide. The combined sample has more than 1,000 PD families. Each study has used rigorous clinical criteria

    to assess their study participants.&lt;/p&gt;

    &lt;p&gt;Unlike previous genome wide association studies (GWAS) in PD, all the PD cases in this proposal have a positive family history

    of disease. In the vast majority of these families, the index PD case has at least one sibling with the disease. Thus, the sample

    is unique for having substantial evidence for a genetic contribution to disease.  The control group for this study consists of

    samples previously collected and maintained by the NINDS Repository.&lt;/p&gt;

 &lt;p&gt;Genome-wide, single nucleotide polymorphism (SNP) genotyping services were provided by the

    &lt;a href="http://www.cidr.jhmi.edu/" target="_blank"&gt;Center for Inherited Disease Research (CIDR)&lt;/a&gt;.&lt;/p&gt;

    &lt;p&gt;Data analyses will focus on the identification of SNPs associated with PD susceptibility and the age of onset of disease.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;These two studies of familial PD have been ongoing for nearly a decade. They have each actively ascertained families with PD and used

    rigorous clinical criteria to assess their study participants. Subjects have been recruited through international collaborations, although

    both studies have primarily recruited Caucasian subjects. Each study has completed extensive genetic analyses to elucidate the role of

    recently identified genes such as &lt;i&gt;parkin&lt;/i&gt; and &lt;i&gt;LRRK2&lt;/i&gt;, as well as to identify novel genetic risk factors. In addition, both studies have

    performed whole genome linkage studies which have detected evidence of specific chromosomal regions influencing PD risk. Thus, a GWA

    study using the combined samples from each study has the potential to maximize the power to detect genetic risk factors of relatively

    small effect size.&lt;/p&gt;
 </StudyHistory><Attributions><Header title="Co-Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Richard H. Myers, PhD</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nathan Pankratz, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Anita L. DeStefano, PhD</AttrName><Institution>Boston University School of Public Health, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jemma B. Wilk, DSc</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William C. Nichols, PhD</AttrName><Institution>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA</Institution></Header><Header title="Co-Investigators"><AttrName>James F. Gusella, PhD</AttrName><Institution>Massachusetts General Hospital, Boston, MA, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. NIH contract "High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Richard H. Myers, PhD</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nathan Pankratz, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Anita L. DeStefano, PhD</AttrName><Institution>Boston University School of Public Health, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jemma B. Wilk, DSc</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William C. Nichols, PhD</AttrName><Institution>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA</Institution></Header><Header title="Co-Investigators"><AttrName>James F. Gusella, PhD</AttrName><Institution>Massachusetts General Hospital, Boston, MA, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. NIH contract "High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Richard H. Myers, PhD</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nathan Pankratz, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Anita L. DeStefano, PhD</AttrName><Institution>Boston University School of Public Health, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jemma B. Wilk, DSc</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William C. Nichols, PhD</AttrName><Institution>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA</Institution></Header><Header title="Co-Investigators"><AttrName>James F. Gusella, PhD</AttrName><Institution>Massachusetts General Hospital, Boston, MA, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. NIH contract "High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Principal Investigators"><AttrName>Richard H. Myers, PhD</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nathan Pankratz, PhD</AttrName><Institution>Indiana University School of Medicine, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Anita L. DeStefano, PhD</AttrName><Institution>Boston University School of Public Health, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jemma B. Wilk, DSc</AttrName><Institution>Boston University School of Medicine, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William C. Nichols, PhD</AttrName><Institution>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA</Institution></Header><Header title="Co-Investigators"><AttrName>James F. Gusella, PhD</AttrName><Institution>Massachusetts General Hospital, Boston, MA, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. NIH contract "High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="GenePD" url="http://www.bu.edu/genepd/"/><Url name="PROGENI" url="http://progeni.iu.edu/"/></StudyURLs><Publications><Publication><Pubmed pmid="17804834"/></Publication><Publication><Pubmed pmid="17078063"/></Publication><Publication><Pubmed pmid="16997464"/></Publication><Publication><Pubmed pmid="15680455"/></Publication><Publication><Pubmed pmid="17190945"/></Publication><Publication><Pubmed pmid="16769863"/></Publication><Publication><Pubmed pmid="16344533"/></Publication><Publication><Pubmed pmid="15966003"/></Publication><Publication><Pubmed pmid="17804834"/></Publication><Publication><Pubmed pmid="17078063"/></Publication><Publication><Pubmed pmid="16997464"/></Publication><Publication><Pubmed pmid="15680455"/></Publication><Publication><Pubmed pmid="17190945"/></Publication><Publication><Pubmed pmid="16769863"/></Publication><Publication><Pubmed pmid="16344533"/></Publication><Publication><Pubmed pmid="15966003"/></Publication><Publication><Pubmed pmid="17804834"/></Publication><Publication><Pubmed pmid="17078063"/></Publication><Publication><Pubmed pmid="16997464"/></Publication><Publication><Pubmed pmid="15680455"/></Publication><Publication><Pubmed pmid="17190945"/></Publication><Publication><Pubmed pmid="16769863"/></Publication><Publication><Pubmed pmid="16344533"/></Publication><Publication><Pubmed pmid="15966003"/></Publication><Publication><Pubmed pmid="17804834"/></Publication><Publication><Pubmed pmid="17078063"/></Publication><Publication><Pubmed pmid="16997464"/></Publication><Publication><Pubmed pmid="15680455"/></Publication><Publication><Pubmed pmid="17190945"/></Publication><Publication><Pubmed pmid="16769863"/></Publication><Publication><Pubmed pmid="16344533"/></Publication><Publication><Pubmed pmid="15966003"/></Publication><Publication><Unparsed>Nichols WC, Elsaesser VE, Pankratz N, Pauciulo MW, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Parkinson Study Group-PROGENI Investigators. 
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. 
Neurology. 2007 Oct 30; 69(18):1737-44. 
Note:PROGENI 

Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group-PROGENI Investigators. 
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. 
Mov Disord. 2006 Dec; 21(12):2257-60. 
Note:PROGENI 

Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group - PROGENI Investigators. 
Mutations in DJ-1 are rare in familial Parkinson disease. 
Neurosci Lett. 2006 Nov 20; 408(3):209-13. 
Note:PROGENI 

Nichols WC, Pankratz N, Hernandez D, Pais?Ru?C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T, Parkinson Study Group-PROGENI investigators. 
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. 
Lancet. 2005 Jan 29-Feb 4; 365(9457):410-2. 
Note:PROGENI 

Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Berg CJ, Sun M, Goldwurm S, Pezzoli G, Racette BA, Perlmutter JS, Parsian A, Baker KB, Giroux ML, Litvan I, Pramstaller PP, Nicholson G, Burn DJ, Chinnery PF, Vieregge P, Slevin JT, Cambi F, MacDonald ME, Gusella JF, Myers RH, Golbe LI. 
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. 
Neurology. 2006 Dec 26; 67(12):2206-10. 
Note:GenePD 

Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. 
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. 
Arch Neurol. 2006 Jun; 63(6):826-32. 
Note:GenePD 

Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, Prakash R, Tobin S, Williamson J, Suchowersky O, Labell N, Growdon BN, Singer C, Watts R, Goldwurm S, Pezzoli G, Baker KB, Giroux ML, Pramstaller PP, Burn DJ, Chinnery P, Sherman S, Vieregge P, Litvan I, Gusella JF, Myers RH, Parsian A. 
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. 
Neurology. 2005 Dec 13; 65(11):1823-5. 
Note:GenePD 

Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, DeStefano AL, Latourelle JC, Xu G, Watts R, Growdon J, Lew M, Waters C, Vieregge P, Pramstaller PP, Klein C, Racette BA, Perlmutter JS, Parsian A, Singer C, Montgomery E, Baker K, Gusella JF, Herbert A, Myers RH. 
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. 
Mov Disord. 2005 Sep; 20(9):1188-91. 
Note:GenePD 

</Unparsed></Publication></Publications><Funding>R01 NS037167-10</Funding></StudyInfo><Authority><ICs><IC id="7" name="NINDS" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="TFOROUD" aid="2" auth="eRA" login="TFOROUD" fname="TATIANA" mname="M." lname="FOROUD" email="tforoud@iu.edu"><Role>PI</Role><Organization>INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS</Organization></Person><Person nedid="0013238013" aid="1" auth="cit" login="sutherlandm" fname="Margaret" mname="L" lname="Sutherland" email="sutherlandm@ninds.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010146585" aid="1" auth="cit" login="zhangr" fname="Ran" mname="" lname="Zhang" email="zhangr@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=17904&amp;file=get&amp;page=file" filename="DUC - CIDR Genome Wide Association Study in Familial Parkinson Disease (PD).docx" md5="8e35a7d280f44da14c14a7672fba5ecf" size="66781" modDate="2015-12-02T16:20:47-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=17906&amp;file=get&amp;page=file" filename="DUC - CIDR Genome Wide Association Study in Familial Parkinson Disease (PD).docx.pdf" md5="f5e3f8b287b9d0fb3e28e4d7daf88ddc" size="165348" modDate="2015-12-02T16:25:20-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="3" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="53" dac_name="NINDS" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="4" CGType="cg_class_DS" title="Disease-Specific (Parkinson's Disease and Related Disorders, NPU)" name="DS-PDRD-NPU" dac_uid="53" dac_name="NINDS" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Parkinson's Disease and Related Disorders.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="3"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>